Recent Posts
- MicroRNA-Mediated Metastasis Suppression
- A New Explanation Of ‘Asian Paradox’
- Toward Bold New Anti-cancer Medicines
- Celsion And Yakult Honsha Announce Treatment Of First Patient In Japan In Celsion’s Global Phase III ThermoDox(R) Trial For Primary Liver Cancer
- $6.5 Million Gift To UCSF From Irwin And Joan Jacobs For Head And Neck Cancer Research
Random Posts
- Revealing Critical Link In Cell Death Pathway
- Study Says High-Cost Cancer Drugs Have Little Benefit, Strain Health System
- Novel Drug Boosts Standard Antiemetic Treatments
- Metatastic Breast Cancer - New Dosing Schedule Suggests Potential Amplified Clinical Activity Of Novel KSP Inhibitor
- Medicare Cuts Will Force Many Cancer Centers To Close, Stop Seeing Medicare Patients, Lay Off Staff, According To ASTRO Survey
- PARP Inhibitor Shows Specificity for BRCA Tumors (CME/CE)
- Novel Cell Therapies To Treat Cancer
- Meta-Analysis Clarifies AML Treatment (CME/CE)
- Patient Response To Therapy For Gastrointestinal Stromal Tumors May Be Predicted By Gene Signature
- Most Colorectal Cancer Screening Will Cut Costs (CME/CE)
Prescription Cancer Drugs
A New Explanation Of ‘Asian Paradox’
Posted by: admin in Prescription Cancer Drugs on November 08th, 2009
Although Helicobacter pylori (H. pylori) has been classified as a class I (or definite) carcinogen by World Health Organization (WHO), the controversy as to why only a minority of infected patients develop gastric cancer still remains. Moreover, in Asian countries such as Indonesia, Japan, China, and Thailand, where the H. pylori infection rates are similar, there is a significant difference regarding the outcome of gastric cancer. That fact has been termed the “Asian paradox”.
A research article published in the World Journal of Gastroenterology addresses this question. Research, led by Murdani Abdullah, MD from Division of Gastroenterology, Department of Internal Medicine, University of Indonesia, was based on the old concept of a cascade of mucosal changes that develops from acute/chronic gastritis to gastric cancer as proposed by P. Correa. The difference in the pattern of H. pylori-associated gastritis may explain the difference in the incidence of gastric cancer between Indonesia and Japan. Previous studies have never evaluated the cascade of gastric mucosal changes prior to gastric cancer. In this research, the transformation of gastric mucosa that is induced by H. pylori infection prior to gastric cancer was investigated. The transformation was then compared between Indonesian and Japanese patients, the two countries that represent the “Asian paradox”.
From 1998 to 1999, 42 Japanese patients at Yamanashi Medical University Hospital, Koufu and 125 Indonesian patients at Metropolitan Medical Centre Hospital, Jakarta were consecutively enrolled. From this research, it was seen that there was a significant difference in the grade and activity of gastric mucosal changes between Indonesian and Japanese H. pylori-positive patients. This finding suggests that there may be a different host response between Indonesian and Japanese people regarding H. pylori infection. The authors believe that lifestyle and genetic factors are considered to play a major role, in the meantime, their research may act as the initial step in explaining the “Asian paradox”.
Reference: Abdullah M, Ohtsuka H, Rani AA, Sato T, Syam AF, Fujino MA. Helicobacter pylori infection and gastropathy: A comparison between Indonesian and Japanese patients. World J Gastroenterol 2009; 15(39): 4928-4931 http://www.wjgnet.com/1007-9327/15/4928.asp
Source: Jin-Lei Wang
World Journal of Gastroenterology
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.